PHO’s laboratory utilizes the MGISP-960 platform to assist in performing automated nucleic acid extraction for downstream testing of covid-19. PHO is seeking information regarding the available reagents and consumables within the market that can be supported on these systems, in order to guide PHO’s strategic planning in regards to ongoing procurements for covid-19 testing.
BPA FOR PCR AND ANTIGEN COVID-19 TESTING Solicitation ID/Procurement Identifier: 19QA1022A0013 Ultimate Completion Date: Tue Apr 16 17:00:00 GMT 2024
District data indicates a significant increase in students being diagnosed with Type I Diabetes after testing positive for COVID-19. Additionally, the district experienced nurse absences related to COVID-19 as well as vacancies due to competitive pay and increased demand from other companies and organizations.
District data indicates a significant increase in students being diagnosed with Type I Diabetes after testing positive for COVID-19. Additionally, the district experienced nurse absences related to COVID-19 as well as vacancies due to competitive pay and increased demand from other companies and organizations.
